Prostate Cancer - Results from #18640

Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to PRIAS criteria - Abstract April 24, 2015

Analysis of side effect profile of alopecia, nail changes, peripheral neuropathy, and dysgeusia in prostate cancer patients treated with docetaxel and cabazitaxel - Abstract April 24, 2015

Four flawed arguments against prostate-specific antigen screening (and 1 good one) - Abstract April 24, 2015

Ethnic differences in patients' preferences for prostate cancer investigation: A vignette-based survey in primary care - Abstract April 23, 2015

Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health and Irish Cancer Society join to advance cancer research April 23, 2015

Renowned urologist appointed president-elect of LUGPA April 23, 2015

Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate - Abstract April 23, 2015

Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity - Abstract April 23, 2015

The Royal College of Radiologists' audit of prostate brachytherapy in the year 2012 - Abstract April 23, 2015

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications - Abstract April 23, 2015

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer - Abstract April 23, 2015

Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer - Abstract April 22, 2015

Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database - Abstract April 22, 2015

Comparison of pathological and biochemical outcomes after radical prostatectomy in Korean patients with serum PSA ranges - Abstract April 22, 2015

Risk stratification of prostate cancer in the modern era - Abstract April 22, 2015

Disease-specific and patient-reported outcomes under active surveillance - Abstract April 22, 2015

Expert’s Corner: Mitchell Sokoloff, MD, recommends PSA screening April 22, 2015

Enzalutamide: A review of its use in chemotherapy-naïve metastatic castration-resistant prostate cancer - Abstract April 22, 2015

Reprint of: The prostate cancer genome: Perspectives and potential - Abstract April 22, 2015

Early outcome of prostate intensity modulated radiation therapy (IMRT) incorporating a simultaneous intra-prostatic MRI directed boost - Abstract April 22, 2015

Page 933 of 1457